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ABSTRACT The O-specific antigen (OSA) in Pseudomonas aeruginosa lipopolysaccharide is highly varied by sugar identity, side
chains, and bond between O-repeats. These differences classified P. aeruginosa into 20 distinct serotypes. In the past few de-
cades, O12 has emerged as the predominant serotype in clinical settings and outbreaks. These serotype O12 isolates exhibit high
levels of resistance to various classes of antibiotics. Here, we explore how the P. aeruginosaOSA biosynthesis gene clusters
evolve in the population by investigating the association between the phylogenetic relationships among 83 P. aeruginosa strains
and their serotypes. While most serotypes were closely linked to the core genome phylogeny, we observed horizontal exchange of
OSA biosynthesis genes among phylogenetically distinct P. aeruginosa strains. Specifically, we identified a “serotype island”
ranging from 62 kb to 185 kb containing the P. aeruginosaO12 OSA gene cluster, an antibiotic resistance determinant
(gyrAC248T), and other genes that have been transferred between P. aeruginosa strains with distinct core genome architectures.
We showed that these genes were likely acquired from an O12 serotype strain that is closely related to P. aeruginosa PA7. Acqui-
sition and recombination of the “serotype island” resulted in displacement of the native OSA gene cluster and expression of the
O12 serotype in the recipients. Serotype switching by recombination has apparently occurred multiple times involving bacteria
of various genomic backgrounds. In conclusion, serotype switching in combination with acquisition of an antibiotic resistance
determinant most likely contributed to the dissemination of the O12 serotype in clinical settings.
IMPORTANCE Infection rates in hospital settings by multidrug-resistant (MDR) Pseudomonas aeruginosa clones have increased
during the past decades, and serotype O12 is predominant among these epidemic strains. It is not known why theMDR pheno-
type is associated with serotype O12 and how this clone type has emerged. This study shows that evolution of MDRO12 strains
involved a switch from an ancestral O4 serotype to O12. Serotype switching was the result of horizontal transfer and genetic re-
combination of lipopolysaccharide (LPS) biosynthesis genes originating from anMDR taxonomic outlier P. aeruginosa strain.
Moreover, the recombination event also resulted in acquisition of antibiotic resistance genes. These results impact on our under-
standing of MDR outbreak strain and serotype evolution and can potentially assist in better monitoring and prevention.
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Lipopolysaccharide (LPS) of the Gram-negative cell envelope isa first point of contact with the external environment, and it is
a major virulence factor of Pseudomonas aeruginosa. LPS has been
reported to be a target for antibiotics, bacteriophages, pyocins,
and other extracellular molecules affecting the cell (1–5). Hence,
we hypothesize that there is selective pressure on LPS and related
biosynthesis in order to adapt to the external environment. Evi-
dence that would support this hypothesis include the observation
of increased mutational frequency in single LPS-related genes,
such as wbpM (encoding a dehydratase and key enzyme in the
biosynthesis of O-specific antigen [OSA]) and waaL (O-antigen
ligase), and the contribution of phosphorylation in the core oli-
gosaccharide toward intrinsic resistance of P. aeruginosa to anti-
biotics (1, 6, 7).
P. aeruginosa simultaneously produces two forms of LPS that
differ in their O antigen, named common polysaccharide antigen
(CPA) and O-specific antigen (OSA). CPA is a shorter and less
immunogenic polysaccharide than OSA, yet CPA has been linked
to chronic lung infections in patients infected with P. aeruginosa
(8, 9). CPA biosynthesis is orchestrated by a cluster of 13 contig-
uous genes (PA5447 to PA5459) as well as algC (PA5322) (8, 10,
11). However, CPA production has been detected in only 14 of the
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20 International Antigenic Typing Scheme (IATS) serotypes (not
produced in serotypes O7, O12, O13, O14, O15, and O16) (12,
13).
Unlike CPA, OSA is constitutively produced by all strains of
P. aeruginosa and is highly diverse. The differences that arise from
inter- or intramolecular bond orientation, O-repeat lengths, and
side groups allow P. aeruginosa to be classified into 20 distinct
serotypes (O1 to O20) in the IATS (14–16). The OSA clusters of
the 20 serotypes can be divided into 11 highly divergent gene clus-
ters with variation in genetic contents (17). The localization of the
cluster in the P. aeruginosa genome is nonetheless conserved and
clearly marked by its being flanked by the himD (also called ihfB)
(PA3161) and wbpM (PA3141) genes (18–20). The high diversity
of the LPS cluster makes it difficult to investigate whether the
LPS-OSA genes are involved in adaptation, as genes in this region
will be neglected in the algorithms used for conventional analysis
of conserved genes from the core genome.
Population studies of P. aeruginosa have revealed the dynamics
of the serotyping characteristics. As a case in point, a recent study
showed that 35% of the P. aeruginosa isolates could not be sero-
typed, particularly among cystic fibrosis (CF) isolates, whereby
33/43 strains examinedwere nontypeable using a commercial typ-
ing kit (21). Another study that included 145 isolates found that
9.6% could not be serotyped, with 11 being polytypeable and 3
being nontypeable. Of the isolates that were assigned specific se-
rotypes, serotype O11 was the most prevalent in population stud-
ies (representing 20.1 to 35.1%), followed by O6 (13.1 to 14.2%),
O1 (11 to 11.9%), and O12 (6.2 to 7.9%). The relatively high
frequency of O12 might be caused by sample bias, due to the
prevalence of O12 strains with many hospital outbreaks of
P. aeruginosa infections. Nonetheless, the worldwide occurrence
of persistent MDR multilocus sequence type 111 (ST111) clones
and known O12 strains, provides the rationale for investigating
whether there is a correlation between a specific serotype and
MDR strains in this species (21–25). In comparison, a study in-
volving non-CF clinical isolates showed a greater variation of se-
rotypes, with themost prevalent serotypes beingO11 (26.8%) and
O12 (16.2%), both of which are known to be associated with a
higher frequency of MDR clones (26).
Our understanding of the relationship between serotype and
the properties of an isolate is limited, and analysis of genomic
diversity of the serotypes has not been performed. Such an analysis
will be affected by the sequence diversity of the P. aeruginosa ge-
nome being very low both on a local and global scale (27, 28), and
some distinct LPS genes may be located in the pangenome of
P. aeruginosa. The sequence diversity in conserved genes has been
found to be 0.3%,making it 1 order ofmagnitude lower than those
in organisms such as Salmonella. Despite studies designed for
identifying niche-specific clones within the P. aeruginosa species,
no link has been identified between ecological setting and geno-
type. The same clones have been isolated across a wide range of
unrelated habitats with the same variant being able to predomi-
nate in several unrelated niches (27, 28).
To gain further knowledge of the diversity of serotypes among
P. aeruginosa bacteria, this study uses comparative genomics to
investigate the genomic evolution of the P. aeruginosa population
in relation to LPS structure and determine whether LPS structures
and serotype play significant roles in the evolutionary trajectory of
P. aeruginosa clones.
RESULTS
In silico serotyping of P. aeruginosa isolates. To investigate the
genomic structure of LPS biosynthesis genes in the P. aeruginosa
population, the OSA and CPA gene clusters were analyzed in 83
P. aeruginosa isolates (see Table S1 in the supplemental material).
These isolates include the 20 IATS serotype strains (O1 to O20)
and 10 published isolates from a range of environments or hospi-
tal outbreaks, including serotype O12 and nontypeable isolates
(21). A group of 52 isolates previously used by Stewart et al. (29)
for investigation of the P. aeruginosa population structure were
used as representatives for a wide range of environments and
times (Table S1). In addition, a known O12 MDR transmissible
ST111 isolate was included as a control together with a genetically
distinct O12 isolate from the PA7 group (included in the popula-
tion used by Stewart et al. [29]). For all the isolates, the CPA and
OSA gene clusters were identified and annotated based on whole-
genome annotation using the RAST server (30). The gene clusters
were then compared across isolates to define subgroups among
the population. The CPA cluster structure was found to be rela-
tively conserved among the 20 IATS serotypes, while the OSA
cluster demonstrated a high degree of diversity as anticipated (17).
Fourteen of the 20 serotypes share the same organization in the
CPA gene cluster, and the strains that differ from this group do so
by divergence in single genes. The only exception is the O12 IATS
strain, which lacks the operon of five genes (PA5455 to PA5459)
that is contiguous to the eight-gene cluster (see Fig. S1 in the
supplemental material).
The variations in the P. aeruginosa OSA gene cluster structure
were outlined by Raymond et al. (17) and showed 11 distinct OSA
cluster structures among the 20 IATS serotypes. In the present
study, the observed OSA cluster structures were confirmed, and
these distinct gene clusters were used for determining the genetic
serotype of all the isolates (see Table S1 in the supplemental ma-
terial). This in silico serotyping revealed 22 serotypeO6 isolates, 14
O2 (which comprises O2, O5, O16, O18, and O20) isolates, 8
O11/O17 isolates, 7 O12 isolates, 6 O10/O19 isolates, 5 O1 iso-
lates, 4 O3 isolates, 3 O4 isolates, 2 O13/14 (only the type strains)
isolates, and 1 O15 (only the IATS) isolate. Four isolates were
found to be nontypeable by this approach, meaning that a single
definitive hit to an entire OSA cluster could not be identified (Ta-
ble S1). As such, all except three serotypes were represented
among the analyzed isolates, and over half of the population was
represented by 8 of the 20 serotypes. Themost predominant sero-
type is O6 (~27%), which is consistent with observations reported
in other population studies (21).
Four CF isolates described as nontypeable by Pirnay et al. (21)
were also examined. These isolates were serotyped in silico, and it
was found that one isolate belonged to the O9 in silico serotype
(PR42), and the remaining three belonged to the O6 in silico sero-
type (PR195, PR196, and Li010). For the remaining six isolates
from the Pirnay collection, four were identified as O12 serotype
isolates (O12-4, O12-17, O12-1709, and PR317 isolates), and the
remaining two were found to be O2 (PR276) and O11 (PR233)
(see Fig. S1A and S1B in the supplemental material).
Genomic evolution of P. aeruginosa is linked to serotype. To
correlate the in silico serotypes with the genomic architectures of
the P. aeruginosa population, a maximum likelihood phylogeny
based on single nucleotide polymorphisms (SNPs) identified in
the core genome was constructed (Fig. 1). The phylogenetic orga-
Thrane et al.
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nization shows four distinct groups, groups A to D (Fig. 1). The
majority of the isolates analyzed (77/83) fall into two groups, a
major one (group A), and a minor one (group B) (Fig. 1). Fur-
thermore, a very distantly related group containing the O12 IATS
serotype isolates PA7 and VRFPAO1 was found (group D in
Fig. 1). Most of the strains examined could be distributed into
three phylogenetic groups; this corresponds well with the struc-
ture of the core genome phylogeny reported by Stewart et al. (29).
Interestingly, an additional group closely related to group A and
group B was also identified, and this new group was populated by
two isolates belonging toO13 andO14 IATS serotypes (groupC in
Fig. 1). The 20 IATS serotype strains analyzed were distributed
across the phylogeny (Fig. 1). Projection of the in silico serotypes
of all the sequenced P. aeruginosa isolates back onto themaximum
likelihood phylogeny revealed that within the four phylogenetic
groups, there was often a clear clustering of the isolates sharing in
silico serotype with their corresponding IATS serotype isolate
(Fig. 1). This was observed for theO10/O19,O2, andO1 in silico
serotype isolates (Fig. 1). On the other hand, the O6 in silico sero-
type isolates were distributed across group A of the maximum
likelihood phylogeny, while theO11 in silico serotype isolates were
found within group B (Fig. 1). In most cases, a certain serotype
found in one phylogenetic group was not found in others. How-
ever, there are exceptions, and deviations from this trend include
the IATS serotype pairs O7/O8 and O11/O17. Each pair of these
serotypes share highly similar OSA gene structures, suggesting
that each pair shares a common ancestor. Nevertheless, for each of
the two pairs, we found one isolate in group A and the other in
group B of the maximum likelihood phylogeny (Fig. 1).
It was intriguing to observe that the sevenO12 in silico serotype
strains identified among the 83 isolates were located in two dis-
tinct groups in the maximum likelihood phylogeny (Fig. 1). The
O12 IATS serotype strain was grouped with strains PA7 and VR-
FPAO1, thus defining group D of the phylogeny, while the other
FIG 1 Maximum likelihood phylogeny based on SNPs in the core genomes of 81 P. aeruginosa isolates. The phylogeny was estimated using the parsnp software
program (45). All isolates are marked according to their in silico serotype by the colors and shapes outlined in the key. For example, isolates marked with a green
box have been typed to anO1 in silico serotype. The groups referred to in the article are shaded and named groups A, B, C, andD. IATS serotype reference isolates
are indicated by a black line outlining the in silico serotype symbol. The tree is represented with the branch for group D shown to scale in the black box or inset.
Strains marked by an asterisk represent the 10 isolates sequenced in this study from the Pirnay collection (21). The scale bar indicates the relative distances of the
branches in the phylogenetic tree.
Pseudomonas aeruginosa Serotype O12 Evolution
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five O12 strains, ST111, O12-4, O12-17, O12-1709, and PR317,
were placed together on a branch in group A. Based on their
genomic structures, these five strains were most related to the
VRFPAO2 strain, which was determined to be an O4 in silico se-
rotype (Fig. 1). These results demonstrate that strains with similar
genomic architectures can exhibit different serotypes (e.g., ST111
versusVRFPAO2) andpoint toward a potential role for horizontal
transfer of serotype-defining genes.
Horizontal gene transfer drives serotype switch to the O12
serotype. To test the hypothesis that the serotype O12 OSA gene
cluster has been horizontally transferred among distinct clone
types, we first examined the relationship between the OSA genes
from the different O12 in silico serotype isolates. No sequence
variations in theOSA gene cluster among theO12 groupA isolates
could be discerned (Fig. 2). Importantly, the genes within theOSA
cluster of these O12 group A isolates were identical to those found
in isolate PA7 from group D (Fig. 2).
To investigate whether horizontally transferred DNA extends
beyond the OSA gene cluster, we characterized the genomic dif-
ferences between the serotype O12 strains from groups A and D.
Inspection of the number of SNPs in the core genomes in all seven
O12 in silico serotype isolates revealed that the three group D
isolates differed from group A isolates by 200,000 SNPs. The
number of SNPs was estimated relative to the core genome of the
O12-4 isolates, includingO12-17 (30 SNPs),O12-1709 (41 SNPs),
ST111 (85 SNPs), PR317 (190 SNPs), VRFPAO2 (2343), PA7
(201.599 SNPs), VRFPAO1 (202.507 SNPs), and O12 (204.506)
(see Fig. S2 in the supplemental material). With such a high num-
ber of SNPs in their core genome, the mean sequence identity
between isolates from each of the two clusters would not be ex-
pected to exceed 97%. The regions flanking the OSA gene cluster
in the five group A isolates were examined for sequence identity
with isolate PA7. On the basis of these analyses, we identified an
~70-kb genomic region that showed close to 99% identitywith the
same region in PA7, whereas the flanking regions showed only 93
to 94% identity (Fig. 3A). The ~25-kbOSA gene cluster was local-
ized centrally in the PA7-like genomic region (Fig. 3A). In sum-
mary, these results demonstrate that a large genomic region en-
FIG 2 Sequence homology matrix of the serotype O12 OSA gene cluster showing the number of sequence differences. Identity is determined based on an
ungapped sequence alignment. Isolates from group A and group D are marked in the figure for comparison.
FIG 3 Outline of the genomic region in isolate PA7 containing the serotype island. (A) The PA7 backbone is shown with the corresponding GC skew and
placement of the O12 OSA cluster. Below the PA7 backbone, the size and identity (percent identity [%ID]) of the sequence from the four O12 in silico serotype
isolates and a higher-magnification view into the two gap regions, where the serotype island is proposed to have inserted into the genome, are depicted. (B) The
proposed architecture of the serotype island in the O12 serotype-switched isolates is depicted with the recombination sites highlighted.
Thrane et al.
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compassing theOSA genes has been horizontally transferred from
a member of the PA7 group to a serotype O4 strain, which has
evolved into the group represented by the five O12 isolates in
group A (ST111, O12-4, O12-17, O12-1709, and PR317 isolates).
Acquisition and recombination of the “serotype island” resulted
in displacement of the native OSA gene cluster in the recipient
strain.
When further analyzing the breakpoint regions of the ~70-kb
“serotype island” sequence, we identified multiple IS insertion
sites in the upstream region of the island (Fig. 3A). The potential
downstream breakpoint coincided with an intergenic palindrome
sequence found in all P. aeruginosa isolates on the Pseudomonas
Genome Database (31) (Fig. 3A). Both of these sequence motifs
have been reported to be prone to homologous recombination. A
closer examination of the flanking sequences in four of the five
serotype-switched O12 isolates (O12-4, O12-17, O12-1709, and
PR317) revealed that they are identical and all have the serotype
island inserted in the oprB gene upstream and at an intergenic
palindrome between ibpA and PA325 downstream (Fig. 3B). Due
to a reduced sequencing quality of ST111, that particular O12
isolate could not be included in this analysis.
Genetic and immunochemical screens of LPS characteristics
of O12 isolates. To determine whether the OSA structure is ex-
pressed on the cell surfaces of these isolates, genetic and immuno-
chemical experiments were performed. TheOSA cluster of each of
the isolates, O12-4,O12-17,O12-1709, andPR317 isolates, and an
IATS O12 control strain was amplified using O12-specific prim-
ers, yielding a single band at 0.8 kb. In contrast, theOSA clusters of
non-O12 isolates PR276, PR196, PR195, LiO10, PR42, and PR233
did not amplify (see Fig. S3A in the supplemental material). To
screen the LPS produced on the cell surfaces of these P. aeruginosa
isolates, LPS prepared from each of the O12 isolates as well as that
from the O12 control were subjected to analysis by Western im-
munoblotting. The monoclonal antibody (MAb) specific to sero-
type O12 (MF35-4) (32) reacted to LPS prepared from isolates
O12, O12-4, O12-7, O12-1709, and PR317 (Fig. 4). To confirm
the total absence of O4 serotype genes, the candidate O12 samples
were probedwith aMAb specific to serotypeO4 (MF31-4), result-
ing in no discernible signal (see Fig. S3C in the supplemental ma-
terial). To standardize the sample loading, an inner-core-specific
MAb (5c7-4) was used, and it recognized a low-molecular-weight
LPS band near the dye front of the gel and blot, and the intensity of
this bandwas consistent among the samples, regardless of whether
the OSA was expressed or not (Fig. 4).
Annotation of the “serotype island.” The number of new
genes transferred via insertion of the “serotype island” was evalu-
ated by annotation of the island (based on the annotation avail-
able from isolate PA7) and identification of orthologous genes
(see Table S2 in the supplemental material). The “serotype island”
comprises 63 genes (PSPA7_1944 to PSPA7_2005), including
gyrA and three genes encoding an efflux pump of unknown func-
tion (PSPA7_1991 to PSPA7_1993). Interestingly, isolate PA7
contains a gyrAC248T (C-to-T change at position 248 encoded by
gyrA) allele known to contribute to the high level of ciprofloxacin
resistance observed in this strain (MIC of128 g/ml [33]). All
five O12 serotype isolates in group A (ST111, O12-4, O12-17,
O12-1709, and PR317) contained this C248T mutation in their
respective gyrA gene, and these five isolates share a near-complete
sequence identity with gyrA from isolate PA7, therefore substan-
tiating the acquisition of this island from a PA7-like isolate
(Fig. 5). In addition, the gyrA genes in these five isolates share high
FIG 4 Serotype screen of P. aeruginosa isolates using in vitromethods. West-
ern immunoblotting probed with MAbs specific to the O12 OSA (MF35-4)
and inner coreD (5c7-4). TheO12OSA antibody reacts strongly in the lanes of
the identified O12 isolates. The appearance of the inner core MAb reactivity
demonstrates equal loads for all samples.
FIG 5 Sequence homology matrix of the gyrA gene showing the number of sequence differences. Isolates originating from group A (serotype switched) and
group D (PA7 like) are shown in the table. All included isolates are of the O12 in silico serotype except for isolate VRFPAO2 (O4 in silico serotype) from group
A.
Pseudomonas aeruginosa Serotype O12 Evolution
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or complete sequence identity with the gyrA gene from isolate
PA7, further substantiating the fact that the island has been ac-
quired from a PA7-like isolate (Fig. 5). In contrast, the other O12
isolates of group D (IATS O12 and VRFPAO1) and the O4 strain
fromgroupA (VRFPAO2) are devoid of theC284Tmutation. The
replacement of the native gyrA allele with gyrAC248T correlates well
with elevated ciprofloxacin resistance (MIC of 8 g/ml) ob-
served in ST111 (22). We note that isolate PA7 has a MIC of
128 g/ml, implying that other factors might affect fluoroquino-
lone resistance in this isolate. The five O12 serotype-switched
strains were isolated between 1988 and 2011, which is the period
after ciprofloxacin was introduced into the market to treat bacte-
rial infections (Fig. 6).
Serotype-switched clones dominate the O12 population. A
recent survey (34) of 390 genomes of clinical P. aeruginosa isolates
sampled between 2003 and 2012 from diverse geographical loca-
tions enabled us to inspect additional serotype O12 genomes and
to further assess whether serotype switching in combination with
acquisition of the particular gyrAC248T allele is important for bac-
terial fitness and dissemination. Our hypothesis is that the global
serotype O12 population would contain a larger proportion of
O12 serotype-switched isolates relative to the “native” PA7-like
serotype O12 strains. A recent study by Kos et al. (34) identified a
total of 32 O12 isolates out of 390 sequenced genomes. Among
these O12 isolates, 20 were of the MLST ST111, and five isolates
were MLST ST244. The remaining seven isolates belonged to dis-
parate MLSTs, i.e., ST597, ST292, ST1721, ST1722, ST1762,
ST1747, and ST1120 (Fig. 6A). All 20 ST111 isolates were able to
be grouped with the five previously described O12 serotype-
switched isolates as well as the O4 isolate VRFPAO2 in the maxi-
mum likelihood phylogeny (Fig. 6A). Significantly, we also found
that all 20 ST111 isolates harbored the same 70,000-bp “serotype
island” described above. Intriguingly, of the 32 O12 isolates from
the study of Kos et al. (34), only 2 isolates were found to cluster
with the outliers PA7, VRFPAO1, and the O12 IATS isolate in
groupDof themaximum likelihood phylogeny. The remaining 10
O12 isolates were placed within or near groups A and B, and as
such, they are also distantly related to isolates from group D
(Fig. 6A). Inspection of the OSA clusters in these 10 isolates re-
vealed that serotype switching had also occurred in these isolates,
but in 8 of 10 strains, the “serotype islands” differed in size from
the 70 kbp observed in the ST111 isolates. These islands all con-
tained the serotype O12-defining genes and the gyrAC248T allele
but ranged in size from ~62,000 bp to ~185,000 bp (Fig. 6B).
Overall, our analysis showed that 35 out of 40 O12 genomes that
have been examined are from serotype-switched isolates and that
serotype switching to the O12 serotype occurred on multiple oc-
casions involving recipient strains of various sequence types.
DISCUSSION
Acquisition of genes encoding antibiotic resistance determinants
and virulence factors through horizontal gene transfer is an im-
portantmechanism in the evolution of pathogenic bacteria. LPS is
a major virulence factor in P. aeruginosa, and in this study, we
demonstrate that horizontal exchange of LPS biosynthesis genes
among P. aeruginosa strains has contributed to the dissemination
of the O12 serotype. In the primary case of this study, we docu-
ment the presence of a 70-kb “serotype island” containing the
P. aeruginosa OSA gene cluster, an antibiotic resistance determi-
nant (gyrAC248T) and a number of other genes originating from
the O12 serotype strain PA7 in the genomes of five isolates with a
core genome architecture distinct from that of PA7. Interestingly,
the genome structures of the five isolates cluster together with
strain VRFPAO2 (belonging toO4 in silico serotype), and these six
strains are all of the sequence type ST111 (Fig. 1). This evidence
suggests that the original recipient was an O4 serotype and that
uptake and recombination of the O12 serotype-defining OSA
gene cluster from a PA7-like strain accounted for serotype switch-
ing fromO4 to O12. This result was further supported by analysis
of 20 additional ST111 serotypeO12 isolates that were all found to
contain an identical 70-kb “serotype island.” This strongly sug-
gests that the majority of O12 serotype-switched ST111 strains in
the serotype O12 population (25 out of 40) is the consequence of
a single transfer and recombination event followed by clonal ex-
pansion.
MDR serotype O12 strains are increasingly widespread in hos-
pital settings across Europe, in particular those with the multilo-
cus sequence type ST111 (21, 22, 35, 36). In the early 1980s, sero-
typeO12 strains were relatively rare in clinical infections, and they
were also not associatedwithMDR.However, from themid-1980s
and onward, a number of studies have reported increased fre-
quencies of MDR O12 strains in patients infected with P. aerugi-
nosa (37, 38). It has previously been suggested that this strain
population had a clonal origin (24, 25). A recent systematic study
of 328 P. aeruginosa isolates sampled over 125 years from different
countries further supported the model that this clone type
emerged very recently (in the 1980s) and has since rapidly dissem-
inated in the hospital environment (21). Despite these observa-
tions, the origin and evolution of this clone type are not well un-
derstood. Our results show that evolution of the widespreadMDR
O12 ST111 clone type involved serotype switching from O4 to
O12 in combination with acquisition of the particular gyrAC248T
allele and that this has been a component of the ecological success
of the clone type in relation to infection and dissemination in the
human population in Europe.
We also found evidence that serotype switching to the O12
serotype occurred on multiple occasions involving recipient
strains of sequence types other than ST111 (Fig. 6). At least four
distinct recombination events that resulted in serotype switching
to O12 could be identified, and in these cases, the implicated se-
rotype islands were of different sizes than the 70-kb island identi-
fied in ST111. Interestingly, these genomic events appear to be
geographically restricted, as the 25 serotype-switched ST111
strains were all isolated from Europe and the Americas between
1988 and 2012, while the other serotype-switched strains came
from the Americas and/or Asia (Fig. 6). It is clear that sampling
size and bias can influence this observation, and analyses of addi-
tional strains are required to establish firm conclusions about po-
tential geographical distributions of these events. Importantly, the
finding of multiple, independent recombination events provide
strong evidence for a selective advantage for this type of genomic
recombination.
The precise selective advantage of serotype switching is not
known, and this should be addressed in future investigations. We
speculate that acquisition of the “serotype island” might have al-
lowed the bacteria to evade the host immune system and the an-
tibodies produced against the previous serotype or to become re-
sistant to bacteriophages (39). A related phenomenon of serotype
recombination that confers a fitness advantage in infections has
been reported for Streptococcus pneumoniae vaccine escape vari-
Thrane et al.
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FIG 6 Characteristics and distribution of the O12 population in relation to the maximum likelihood core genome phylogeny. (A) The maximum likelihood
phylogeny was constructed using the parsnp (49) software program and is represented as a proportional tree. The tree includes 32 O12 isolates described by Kos
et al. (34). These isolates are named according to their identification (ID) number, i.e., isolate 15042 has the original IDAZPAE15042. Also included are the eight
O12 isolates described in the present study. Themultilocus sequence type (MLST) and country and year of isolation (origin and year) for each isolate are shown.
The nature of the “serotype island” (SI) in each of the isolates is indicated by a colored square; blue is a SI of ca. 185 kb, red is a SI of ca. 135 kb, yellow is a SI of
ca. 70 kb, and green is a SI of ca. 62 kb. (B) Schematic overview of the size and position of the different “serotype islands” in relation to the PA7 genome. The color
scheme is the same as in panel A, and the number of MLST types containing the different islands is shown.
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ants (40). The process of serotype switching by recombination has
not previously been reported for P. aeruginosa. It is a completely
differentmechanism compared to serotype switching in P. aerugi-
nosa due to D3 bacteriophage lysogeny reported previously (41),
whereby the switch from P. aeruginosa serotype O5 to O16 was
mediated by phage-derived elements, including an inhibitor pep-
tide called Iap (inhibitor of cognate O-antigen polymerase Wzy)
and an O-antigen polymerase, Wzy, that changes the bond be-
tween O units from  to .
To verify that the O12 OSA cluster was not only acquired but
also expressed in the isolates, in vitro experiments, including PCR
amplification and immunochemical studies, were undertaken. A
previous study by Raymond et al. (17) has shown that OSA-
specific primers can be generated to probe specific genes present
within each serotype cluster. However, a set of O12-specific prim-
ers was not reported in their study; therefore, we followed their
method and designed the primers specific to a region within the
O12 OSA cluster. The primers were deemed specific against O12
strains because amplification of LPS genes was observed only
against chromosomal DNA prepared from O12 strains but not
against DNA prepared from other serotypes (see Fig. S3A in the
supplemental material). To substantiate the PCR amplification
results, we also showed that the acquired O12 OSA cluster is ac-
tively being expressed as shown by LPS from these strains reacting
with the O12-specific MAb MF35-4 in Western blots. The pres-
ence of high-molecular-weight bands in the blots of LPS samples
prepared from the group of O12 in silico serotypes revealed that
O12 LPS is indeed constitutively expressed among these isolates.
The expression of this OSA by non-O12 genetic isolates demon-
strates a selective pressure for this specific repeat.
Although the precise mechanism of transfer of the 70-kb “se-
rotype island” remains unknown, frequent recombination is a
well-documented phenomenon in P. aeruginosa (6, 26, 42). Nev-
ertheless, our finding of multiple events of transfer and recombi-
nation of large DNA fragments ranging in size from~62,000 bp to
~185,000 bp is unusual. Our identification of recombination be-
tween O12 and non-O12 genetic isolates (e.g., between group A
and D strains in Fig. 1) was enabled by our in silico serotyping
approach and the large sequence differences that exist between
these isolates. Interestingly, we note that serotypes other thanO12
(such as O7/O8 and O11/O17) also exhibit varied distributions in
the phylogenetic tree, and may thus represent related examples of
serotype switching by recombination. Furthermore, Dettman et
al. (43) identified thewbpM gene (which is conserved at the 3= end
of all OSA gene clusters) as a region within the P. aeruginosa core
genome that exhibits a high recombination rate. While these ob-
servations are suggestive of additional examples of serotype re-
combination, sequencing of a larger panel of P. aeruginosa ge-
nomes is a logical approach to further our understanding of how
frequent serotype recombination takes place and if this phenom-
enon is relevant for serotypes other than O12. This study is an
important step in understanding P. aeruginosa distribution and
survival, ushering in a new form of serotype identification which
could allow better monitoring of outbreaks and tailored treat-
ments of infection.
MATERIALS AND METHODS
Bacterial isolates and genome sequencing. This study analyzes 83
P. aeruginosa isolates, 30 of which were sequenced as part of the present
work (see Table S1 in the supplemental material). Of the isolates included
in this study, 52 isolates were originally sequenced in a previous study (it
was not possible to obtain data for isolates 138244, 152504, and
NCMG1179) (29). The 20 standard IATS serotype type strains for sero-
types O1 to O20 were described earlier (32) and can be retrieved from
ATCC: O1 to O17 (ATCC 33348 to ATCC 33364), O18 (ATCC 43390),
and O19 and O20 (ATCC 43731 and ATCC 43732). Ten isolates were
chosen from the Pirnay culture collection on the basis of these being from
a range of locations, environments, and time points; this group included
both serotype O12 and nontypeable isolates. A single known hospital
outbreak strain of the O12 ST111 type was included (Table S1). The 10
isolates from the Pirnay collection and the serotype isolates O6 and O17
were sequenced at the Plateforme d’Analyses Génomiques (IBIS, Univer-
sité Laval, Québec, Canada) on an Illumina MiSeq platform generating
300-bp paired-end reads, and the remaining serotype isolates (O1 to O5,
O7 to O16, and O18 to O20) were sequenced on an Illumina HiSeq 2000
platform generating 100-bp paired-end reads by BGI Europe (Copenha-
gen, Denmark).
Construction of the core genome phylogeny. The 20 IATS serotype
isolates and the 10 isolates from the Pirnay collection were assembled
using the A5 Assembly Pipeline, and the assemblies ranged in scaffolds
from78 to 236 (44). Full assembly statistics are displayed inTable S3 of the
supplemental material. The phylogeny was constructed using the parsnp
program from the Harvest software suite (45), which defines the core
genome across all isolates and builds the phylogeny by the maximum
likelihood method using core SNPs across isolates.
Genetic serotyping and exploratory genome analysis.TheOSA clus-
ters of all 20 IATS serotype strains were identified and verified by multi-
BLASTn analysis against the 21 published OSA clusters (17). Hence, the
structure of the OSA gene clusters was confirmed, and it was verified that
the chromosome of each isolate contained only a single OSA cluster. The
CPA clusters of all 20 serotype isolates and the 10 isolates from the Pirnay
collection were identified asmarked bywbpM and ihfB (also called himD)
as flanking genes of the lusters. The region within the OSA locus was then
extracted and analyzed for all isolates. The 30 assemblies were annotated
using the Rapid Annotation using Subsystem Technology (RAST) server
(30) in order to verify the genes in the OSA and CPA clusters.
Using the same multi-BLASTn approach as for OSA verification, the
10 serotypeO12 or nontypeable (NT) isolates and 51 diverse environmen-
tal isolates were genetically serotyped based on the structure of their OSA
cluster. If no hit covering an entire OSA cluster was found, the strain was
deemed nontypeable.
In vitro serotyping through genetic screen and LPS analysis. (i) Bac-
terial growth conditions. The isolates selected for in vitro serotyping are
as follows: O12-4, O12-17, 1709, PR317, PR276, PR196, LiO10, PR195,
PR42, and PR233. Overnight cultures of each isolate were grown in 5-ml
lysogeny broth (LB) (also called Luria-Bertani broth) overnight with
shaking (200 rpm) at 37°C. The following morning, each culture was
separated: 1 ml was set aside for chromosomal DNA isolation, and the
remainder was used for the LPS preparations.
(ii) Chromosomal DNA isolation. The chromosomal DNA was iso-
lated through a combination of the Goldberg and Ohman method (46)
and phenol-chloroform extraction (47). The intermediate aqueous phase
was treated with 5l of 20mg/ml RNase (Life Technologies) for 10min at
37°C. RNase was removed with a final chloroform extraction. Primers
specific to the O12 OSA cluster were designed following the method de-
scribed by Raymond et al. (17). The serotype O12-specific primer set is as
follows: 5=ATGAAAAAAGTTTTGGTTACTGGG 3= and 3=CCCTCTCG
AATCGAGTAGGTAGGCTC 5=. The OSA cluster of the candidate iso-
lates and an O12 IATS control were amplified using the KOD Hot Start
polymerase (Life Technologies) and separated by gel electrophoresis.
(iii) LPS extraction and serotyping using monoclonal antibodies.
The overnight culture of each isolate and of an O12 IATS control were
treated using the proteinase KHitchcock andBrownmethod (48). Briefly,
cells were equilibrated to an optical density at 600 nm (OD600) of 0.45,
resuspended in 250 l of lysis buffer, boiled for 30 min, and treated with
Thrane et al.
8 ® mbio.asm.org September/October 2015 Volume 6 Issue 5 e01396-15
 
m
bio.asm
.org
 o
n
 N
ovem
ber 6, 2015 - Published by 
m
bio.asm
.org
D
ow
nloaded from
 
2 mg/ml of proteinase K (Sigma Aldrich) overnight at 55°C. The LPS was
resolved by electrophoresis on 12% SDS-polyacrylamide gels and visual-
ized by ultrafast silver stain. Western immunoblotting was performed
using monoclonal antibodies (MAbs) generated by the lab to probe for
inner core (MAb 5c-7-4) and serotype O12 (MAbMF35-4). The second-
ary antibody was goat-anti-mouse Fab2 conjugated to alkaline phospha-
tase (Cedarlane).
Sequence data. The assembled genomes of the 20 P. aeruginosa IATS
serotype isolates which have been sequenced and assembled in this study
are available in BioProject PRJNA294638 at NCBI. The 10 Pirnay collec-
tion isolates that have also been sequenced and assembled are available in
BioProject PRJNA294726.
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